ArticleOncotarget2016

Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden.

Liang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.